Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Acquires Bioinformatics Firm OmicSoft

NEW YORK (GenomeWeb) – Qiagen today announced it has acquired bioinformatics firm OmicSoft for an undisclosed amount of cash.

OmicSoft markets a suite of tools that allow researchers to analyze and visualize data and compare them to large, publicly available multi-omics data sets. Qiagen said the acquisition will provide it with scalable and flexible software architecture solutions that will enable it to expand its bioinformatics offerings.

"Through the addition of OmicSoft, Qiagen will now offer solutions across the full spectrum of data management and interpretation needs," the firm said in a statement. 

OmicSoft will operate as a Qiagen subsidiary from its Research Triangle, North Carolina headquarters and its co-founder and president, Jack Liu, will remain with Qiagen.

Qiagen said that it expects 0.5 percent in incremental sales growth on a full-year basis and that the purchase will be neutral to adjusted EPS.

This is the latest acquisition for Qiagen since it completed a tender offer for Danish molecular diagnostics firm Exiqon last June. 

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.